Background: Atrial fibrillation (AF) is a common complication in myocardial infarction (MI). In literature, inflammation has been suggested to play an important role in the pathophysiology of AF. However, whether MI induces atrial inflammation is unknown. Here, we analysed atrial inflammation in patients with MI and in rats with experimentally induced MI. The effect of the anti-inflammatory agent C1-esterase inhibitor (C1inh) on atrial inflammation in rats was also analysed. Methods: In the hearts of patients who died at different time points after MI (total n = 24), neutrophils, lymphocytes, and macrophages were quantified in the left and right atria and the infarcted left and non-infarcted right ventricles and compared to control patients (n = 5). MI was induced by coronary artery ligation in 17 rats, of which ten were subsequently treated with C1-inh for 6 days. Forty-two days post-MI, inflammatory cell infiltration and the endothelial inflammation marker CML was analysed in the myocardium of both the atria and ventricles. Results: In all investigated areas of the human hearts, increased lymphocytes and macrophages were observed to a varying extent, most pronounced from 12 hours to 5 days after MI. Similarly, in rats, MI resulted in an increase of inflammatory cells and CML in the atria. C1inh treatment in turn decreased the amount of atrial inflammation. Conclusions: MI induces atrial inflammation in patients and in rats, which may provide a substrate that predisposes towards AF. C1inh treatment could counteract this MIinduced atrial inflammation in rats.
INTRODUCTION
Myocardial infarction (MI) is a major cause of morbidity and mortality worldwide. An important factor that contributes to MI disease progression is inflammation. Although the inflammatory response that accompanies MI is important in the healing process of the infarcted heart, it also results in additional cell death of ventricular cardiomyocytes leading to increased infarct expansion, fibrosis, and eventually in decreased heart function 1, 2 . MI is primarily induced in the ventricles, therefore the ventricular post-MI inflammatory response has been investigated thoroughly 1, 3, 4 . Less is known about the effect of MI on the non-infarcted areas of the heart. From animal MI studies it is known that left ventricular infarction results in increased fibrosis and remodelling of the right ventricle 5 , albeit unknown is whether this is induced by inflammation of the right ventricle. Additionally, it is known that MI has a profound effect on the atria. F.i., the cardiac hormone atrial natriuretic peptide (ANP), produced by the atria, is secreted into the circulation in MI 6 . Even more, it has been shown that a relation exists between increased levels of ANP, systemic inflammation, and impaired left atrial function in patients with heart failure not related to MI 7, 8 . Next to this, it is known that atrial fibrillation (AF) is a common complication of MI with a reported incidence of 7-21% [9] [10] [11] . In non-MI patients, it has been shown that AF coincides with increased numbers of macrophages 12 and lymphocytes 13 in both the left and right atria. These studies suggest an important role of inflammation in AF. However, it has never been investigated whether atrial inflammation also occurs in MI patients and also it is not precisely known how MI induces AF. C1-esterase inhibitor (C1inh) inhibits the complement system and has been shown to have beneficial effects in MI animal models and MI patients 14, 15 . Next to its effect on the complement system, it was shown that C1inh also binds to the adhesion molecules E-and P-selectin and as such inhibits endothelial-leukocyte binding. The aim of this study was to investigate whether MI results in inflammatory cell infiltration of the atrial myocardium in patients without symptomatic AF, which may indicate a possible mechanism that predisposes patients with MI to the development of AF. We have observed in patients with AF without MI, that inflammatory cells also infiltrate atrial adipose tissue (unpublished results), therefore, we also analysed in patients with MI, the inflammatory cells in atrial adipose tissue. Additionally, we investigated whether MI induces atrial inflammation in a MI rat model and whether C1inh treatment can counteract MI-induced atrial inflammation in these rats.
METHODS

Human heart tissue
Human heart tissue was obtained at autopsy (n = 29). From each patient, tissue samples of the left ventricular wall (infarct area), the non-infarcted right ventricular wall, and the auricles of the left and right atria of the heart were analysed. Infarct age was determined by macroscopical analysis of nitroblue tetrazolium (NBT) staining on left ventricular crosssections of the heart in combination with microscopical analysis of the infarction area. NBT decolourisation without microscopical changes of the myocardium, was diagnosed as a phase 1 MI (P1; 3 -6 hours old). Early phase 2 MI (early P2; 6 -12 hours old), was diagnosed as macroscopic NBT decolourisation with microscopical accumulation of neutrophils in the blood vessels of the affected myocardium. When neutrophils were found extravascular in between affected cardiomyocytes, these patients were diagnosed as late phase 2 MI (late P2; 12 hours up to 5 days old). Finally, phase 3 MI (P3; 5 -14 days old), was diagnosed when microscopically granulation tissue was found 16 . AF may induce inflammation in the atria, therefore, patients with pre-existing symptomatic AF were excluded from this study. Included were six patients with P1 MI, four patients with early P2 MI, four patients with late P2 MI, 10 patients with P3 MI, and five control patients who died of a cause not related to cardiac disease. Details of the included patients can be found in table 1. This study was approved by and performed according to the guidelines of the ethics committee of the VU University Medical Center (VUmc), Amsterdam, and conforms to the principles of the Declaration of Helsinki. Use of the leftover material after the pathological examination has been completed is part of the patient's contract in our hospital.
Rat myocardial infarction model
This study was approved by the VUmc animal ethics and welfare committee, and conforms to the Guide for care and use of laboratory animals published by the US National Institutes of Health. MI was induced in male Wistar rats (n = 17; 240-280 g; Harlan Laboratories, Horst, The Netherlands), by a 40 minute ligation of the left anterior descending coronary artery followed by reperfusion as described previously 17 . Ten minutes after reperfusion, and for six consecutive days thereafter, the rats received a daily bolus of either human plasma-derived C1inh (n = 10; 100 U/kg, Cetor®, Sanquin, Amsterdam, The Netherlands) or vehicle (n = 7; saline) via intravenous injection in the tail vein. As a control, three sham operated rats were included whereby the procedure was identical to the MI group, but without the ligation of the LAD. The rats were killed 42 days after MI. The hearts were excised, fixed in 4% formalin, and the atria and ventricles were embedded in paraffin for immunohistochemical analysis. -(carboxymethyl)lysine (CML, 1:1000) for 1 hour at RT. Human tissue slides were then incubated with Envision TM (undiluted, Dako) for 30 minutes at RT and the rat tissue slides with rabbit anti-mouse biotin (1:500, Dako) for 30 minutes at RT, followed by incubation with streptavidin/HRP (1:100, Dako) for 1 hour at RT. Staining was visualized using 3,3'-diaminobenzidine (0.1 mg/ml, 0.02% H 2 O 2 ). The slides were subsequently counterstained with haematoxylin, dehydrated, and covered. With each staining a PBS control was included for each antibody. All these controls yielded negative results (data not shown).
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Immunoscoring
In the ventricular human tissue slides, the number of extravascular neutrophils, lymphocytes, and macrophages were quantified in the myocardium and not in the epicardial adipose tissue. The total surface area of each sample was measured using QPRODIT v3.2 (Leica Microsystems, Wetzlar, Germany), using a Leica DM/LM microscope. In the atrial human tissue slides, the surface area of the myocardium and adipose tissue was measured separately. The number of extravascular inflammatory cells per mm 2 was calculated as the total score for each specimen. In both the ventricular and atrial rat tissues, the number of extravascular lymphocytes, macrophages and ED2-positive macrophages were quantified in the myocardium. The total surface area of the myocardium of each rat sample was then measured using the Pathscan Enabler IV (Meyer Instruments, Houston, TX) with QuickPhoto Micro software (windows version 3.0, Promicra, Prague, Czech Republic). The number of extravascular inflammatory cells per mm 2 in both the ventricles and the number of extravascular inflammatory cells per mm 2 in both the atria, were calculated as the total immunohistochemical score for each specimen. CML scores were determined as described before 18 , and also divided by the total surface area resulting in a final score of CML intensity per mm 2 . We also analysed the effect on the different intensity scores of CML (1 = minor; 2 = moderate and 3 = strong).
Statistical analysis
Statistics were performed using the SPSS statistics program (windows version 15.0, IBM, New York, NY). Human data were analysed using Mann-Whitney U tests. Rat data were compared using the Kruskal-Wallis test. Holm's correction is applied to the resulting p-values. P-values ≤ 0.05 were considered significant. Correlation analysis was performed using Spearman's correlation coefficient. For correlations, the coefficient of determination (cod) was also determined.
RESULTS
Extravascular neutrophils in the hearts of MI patients
The number of extravascular neutrophils in the myocardium of the LV was significantly increased in MI patients of late P2 only, compared to controls (p = 0.050; figure 1A ). No significant differences were found in the number of neutrophils of the RV, LA, and RA, compared to controls (figure 1B). In the atria, neutrophils were observed to be present in both atrial cardiomyocyte tissue and atrial adipose tissue ( figure 1C ). The number of neutrophils in the adipose tissue of the LA and RA, did not differ significantly compared to controls (figure 1D).
Extravascular lymphocytes in the hearts of MI patients
Compared to controls, the number of extravascular lymphocytes was significantly increased in the myocardium of the LV of early P2 patients (p = 0.014; figure 2A), the LV and LA of late P2 patients (both p = 0.014; figure 2A), and also the RV and RA of late P2 patients (both p = 0.014; figure 2B ). In the myocardium of the LV of P3 patients, a minor but significant increase in lymphocytes was found, compared to controls (p = 0.020; figure 2A ). Lymphocytes were observed to be present in both atrial cardiomyocyte tissue and atrial adipose tissue (figure 2C). In the atrial adipose tissue, the number of lymphocytes was increased in both the LA and RA of early P2, late P2, and P3 patients, which was significant for the LA of early P2 (p = 0.027; figure 2D ) and both the LA and RA of late P2 patients (both p = 0.014; figure 2D ). 
Extravascular macrophages in the hearts of MI patients
The number of extravascular macrophages was significantly increased in the myocardium of the LV in early P2 (p = 0.050), late P2 (p = 0.014), and P3 patients (p = 0.027) and in the myocardium of the LA in late P2 (p = 0.014) and P3 patients (p = 0.037; figure 3A ), compared to controls. In addition, the number of extravascular macrophages was significantly increased in the myocardium of the RV in late P2 (p = 0.014) and P3 patients (p = 0.050) and the RA in early P2 (p = 0.014) and late P2 patients (p = 0.014; figure 3B ), compared to controls. In P3 patients, a strong but non-significant increase in the RA was also found (figure 3B).
Macrophages were observed to be present in both atrial cardiomyocyte tissue and atrial adipose tissue ( figure 3C ). Increased numbers of macrophages were also found in the adipose tissue of both the LA and RA of early P2, late P2, and P3 patients, which was significant in the LA of early P2 (p = 0.050) and late P2 patients (p = 0.014; figure 3D ). Combining all these results, it shows that, to a varying degree, increased numbers of inflammatory cells infiltrate the atria of patients with MI, suggesting that (left) ventricular infarction induces atrial inflammation.
Correlation analysis
In the patient study, we were curious whether the number of inflammatory cells in the ventricles correlated with the number of inflammatory cells in the atria. 
MI-induced atrial inflammation and the effect of C1inh thereon in a rat MI model
To verify whether left ventricular MI indeed induces atrial inflammation, as we observed in patients with MI, we induced ventricular MI experimentally in rats and analysed putative infiltration of inflammatory cells in the atria of these rats. MI induced a significant increase in the number of lymphocytes in the myocardium of the ventricles at 42 days post-MI (p < 0.05). In the sham operated rats, there already was a remarkably large number of lymphocytes in the atria, that did not further increase in the MI group ( figure 4A ). However, MI did induce a significant increase in the number of macrophages in the myocardium of both the ventricles (p < 0.05) and the atria (p < 0.05), compared to sham operated rats ( figure 4B ). These results indicate that MI indeed induces atrial inflammation. Next, we analysed whether post-MI treatment with C1inh prevented this MI-induced atrial inflammation. C1inh treatment reduced the number of MI-induced lymphocytes both in the ventricles and the atria, which was significant in the ventricles (p < 0.05; figure 4A ). Similarly, C1inh treatment reduced the number of macrophages in both the ventricles and atria, although not significantly ( figure 4B ). Previously, in a rat model of burn-induced cardiac inflammation, we found that C1inh treatment induced a more anti-inflammatory (ED2-positive) phenotype of cardiac macrophages 19 . Therefore, we also determined the effect of C1inh on ED2-positivity in our rat MI model. Compared to shams, MI induced a non-significant decrease in the percentage of ED2-positive macrophages in the myocardium of the atria, and did not have any effect in the ventricles ( figure 4C ). In contrast, an increase in the percentage of ED2-positive macrophages was found in both the ventricles and the atria of C1inh-treated rats, compared to vehicletreated rats, albeit, this was not significant (figure 4C). These data indicate that MI induces atrial inflammation, also in rats, and that post-MI inflammation in the ventricles and atria can be reduced by C1inh treatment and likely results in a more anti-inflammatory phenotype. 
MI-induced CML deposition in the intramyocardial vasculature of the rat atria and the effect of C1inh thereon
In a previous study, we observed in rats that MI results in an increased expression of the pro-inflammatory advanced glycation end product N ε -(carboxymethyl)lysine (CML) in the intramyocardial vasculature in the infarcted, but also the non-infarcted areas of the ventricles 18 . We wondered whether CML positivity of the atria would also be induced by MI, and if so, whether this could be inhibited by C1inh. In the ventricles and the atria, CML deposited predominantly in the intramyocardial vasculature. MI induced an increase in the total immunohistochemical vascular CML score in both the ventricles and the atria, compared to sham operated rats, which was significant in the ventricles only (p < 0.05; figure 5A ). Interestingly, C1inh treatment significantly counteracted this MI-induced increase in total immunohistochemical vascular CML score in both the ventricles (p < 0.05) and the atria (p < 0.05; figure 5A ). Next, we evaluated the effect of MI on the different CML intensity scores in both the ventricles and the atria. In both the ventricles (figure 5B) and the atria (figure 5C), the distribution of CML intensity scores were similar in all three groups with the highest number of blood vessels being light-positive (score 1), followed by the number of moderately-positive blood vessel (score 2), and the lowest number of blood vessels being strong-positive (score 3). In vehicletreated rats, a significant increase in all three intensity scores was found in the ventricles (p < 0.05; figure 5B ) and in the atria, in intensity scores 1 and 2 (p < 0.05; figure 5C ), compared to shams. In C1inh-treated rats, a significant decrease in intensity scores 2 and 3 was found in the ventricles (p < 0.05; figure 5B ) and in the atria, in intensity score 2 (p < 0.05; figure 5C ), compared to vehicle-treated rats. These data thus indeed indicate that MI not only induces CML positivity of the intramyocardial vasculature in the ventricles, but also in the atria, generating a pro-inflammatory status of the blood vessels in the atria, that can be prevented by C1inh treatment. Similar to the patient study, we also performed correlation analysis between the ventricles and the atria (supplementary table 4) . Also here, overall no significant correlations were found between the number of inflammatory cells in the ventricles and the atria. 
DISCUSSION
In this study, we observed in patients with MI, that inflammatory cells not only infiltrate the infarcted LV, but also the non-infarcted RV, LA, and RA. The number of macrophages in the non-infarcted areas, were increased from early P2 onward. For the number of lymphocytes, this infiltration was primarily observed during late P2. These observations thus indicate that not only the ventricles, but also the atria of the heart are inflamed post-MI. Additionally, we also demonstrated in rats, that MI can indeed cause atrial inflammation, indicated by the significantly increased numbers of macrophages, and increased CML-positivity in myocardial blood vessels. C1inh treatment, decreased atrial inflammation in the rats. The question arises how local infarction of the ventricles does induce inflammation in other areas of the heart. It is known that in patients with MI global ischemia is induced, inducing a pro-inflammatory status of the blood vessels in whole the heart 18 . Indeed, we also observed increased presence of the pro-inflammatory CML in the blood vessels in both the ventricles and the atria after induction of MI in rats. Global ischemia may thus explain the infiltration of inflammatory cells in the non-infarcted parts of the heart, including the atria, in these patients with MI. Previously, we observed in patients with acute pulmonary embolism, a clinical condition coinciding with RV dysfunction, not only inflammation of the RV, but remarkably also in the LV 20 , indicating that failure of the RV can result in inflammation of the LV. A similar process, albeit reversed, might also occur in patients with MI of the LV, wherein inflammation of the failing LV may subsequently result in inflammation of the RV and the atria. It indeed is known that MI is associated with an increase in circulating catecholamines, facilitating stressinduced damage to the endothelium, and an increased rate of heart failure and mortality 21 . In line with this, in a rabbit MI model, it was found that preischemic efferent vagal stimulation resulted in release of noradrenaline and adrenaline plasma levels and increased infarct size 22 . For this, it can be hypothesized that local and/or systemic production of catecholamines, related to post-MI stress, facilitates infiltration of inflammatory cells in the non-infarcted areas of the heart also, including the atria. In addition, it has been shown in animal models that pre-existent local cardiac macrophages are the first inflammatory cells to be activated, resulting in the secretion of pro-inflammatory cytokines and chemokines post-MI, generating a pro-inflammatory environment, facilitating the influx of additional inflammatory cells in the heart 1, 3, 23 . Interestingly, these pre-existing local macrophages are also present in the atria of non-diseased hearts 24 . Finally, another known pro-inflammatory source of the heart is adipose tissue. Epicardial adipose tissue, surrounding the myocardium of the ventricles, namely, can also produce proinflammatory cytokines which was shown in patients with coronary artery disease and after cardiac surgery 25, 26 . Interestingly, the atria of the heart have large amounts of adipose tissue, not only in the epicardium, but also the myocardium. Indeed, in the present study, we did 7 find increased numbers of inflammatory cells, especially lymphocytes and macrophages, in the adipose tissue in the atria of patients with MI, indicating that the adipose tissue in the atria could also be involved in the inflammatory response in the post-MI heart. AF is a common complication of MI and has been reported to occur in 7-21% of hospitalized patients with MI [9] [10] [11] . With respect to the timing of post-MI newly onset AF, one study reported an occurrence of 15% in the 1-2 days after MI period, 13% in the 3-4 days after MI period and 10% in the 5 days to discharge period, indicating that post-MI AF does occur within the timeframe wherein we observe atrial inflammation 11 . Noteworthy is also the gradual decline in the occurrence of AF in time after MI, the authors reported 11 . This decline may indicate either spontaneous or pharmacologic reversion to sinus rhythm, but possibly also as a result of inhospital deaths 11 . Studies with a longer follow-up have reported a gradual increase of newly onset of AF in the years after MI 27 . However, this may also relate to MI-induced heart failure, as clinical symptoms of heart failure are associated with increased risk of developing AF 28, 29 .
In patients with AF, but without MI, a significant increase in the number of macrophages and lymphocytes in the atria was described 12, 13, 30 , although neutrophilic granulocytes were not included in the analyses. Importantly, it was shown that the inflammatory activity of epicardial adipose tissue in the LA is increased in patients with AF 31 . In line with this, we found increased inflammatory cells in the adipose tissue in the atria of patients with MI. Inflammation of the atria as a consequence of LV MI, as found in our study, possibly can predispose towards increased fibrosis and eventual atrial remodelling, making these patients more vulnerable for the induction of AF. In the present study, we also found beneficial effects of C1inh on the inflammatory response in the post-MI rat heart. Protective effects of C1inh in MI animal models and patients with MI, have previously been described 14, 15 . However, our observation that C1inh decreases MI-induced atrial inflammation in rats has never been published before, as well as our observations that C1inh appears to facilitate a transition to a more anti-inflammatory phenotype of the macrophages in the whole heart, and that C1inh significantly reduces CML positivity in the blood vessels in both the ventricles and atria of post-MI hearts. In contrast to previous animal studies 14 , which measured infarct size several hours following reperfusion, in our rat study, C1inh did not result in a decrease in infarct size at 42 days compared to the control group (data not shown). This indicates that the inhibitory effect of C1inh on the atrial inflammation was likely not due to an effect on the infarct size. Several mechanisms, however, may contribute to these observed effects. First of all, C1inh has been demonstrated previously in an MI swine model, to result in decreased release of anaphylatoxins from the complement cascade 32 . These anaphylatoxins have been described to increase vascular permeability and serve as chemo attractants for leukocytes 33 . This may explain why C1inh results in decreased infiltration of inflammatory cells. Alternatively, C1inh is also known to bind directly to endothelial selectins [34] [35] , which can result in decreased leukocyte adhesion to vessel walls and subsequent infiltration. Beside a decrease in leukocyte infiltrations, anaphylatoxins also trigger production of reactive oxygen species by leukocytes 36 , which may have resulted in the observed increased vascular CML accumulation. Additionally, we previously found that CML accumulation in blood vessels is associated with activated endothelium in patients with MI 18 . The reduced pro-inflammatory status of the blood vessels in the whole heart induced by C1inh, may provide an alternative explanation for the lower number of infiltrated inflammatory cells found in the hearts of these rats. Finally, complement activation has been implicated to play a role in macrophage polarization 37 . Thus, the C1inh-induced relative increase in anti-inflammatory macrophages in the heart can potentially be attributed to inhibition of the complement system also. In short, literature provides a number of possible mechanisms that can explain our observed effects of C1inh in the rat model. Additional research will be needed to unravel the actual underlying mechanisms, as well as, whether this reduction in atrial inflammation also occurs in patients.
Study limitations
Even though post-mortem studies have the benefit over studies performed on living patients in the fact that a much larger amount of tissue is available for immunohistochemical analysis and the availability of cardiac tissue from control patients without cardiac abnormalities, several important limitations are also present. First of all, the clinical information of autopsied patients is mostly limited to pathological findings made at autopsy in combination with the recorded medical history of the patient, while information on cardiac function before death is often incomplete. In addition, any form of follow-up or interventional analysis for this type of study is impossible. Another limitation for this study specifically is the facts that the observations made here are based on a relatively small number of patients.
Conclusion
In conclusion, we have demonstrated that in patients with MI, MI results not only in inflammation of the infarct area, but also in non-infarcted areas of heart, namely the RV and the atria. In addition, we found that inflammation of the atria also occurs in a rat model of MI and that in these rats, atrial inflammation can be decreased with C1inh treatment. The observed atrial inflammation may provide an underlying mechanism that predisposes patients with MI to the development of AF. However, the causal relation between inflammation and AF remains controversial, and it would require further research in living patients to determine whether MI-induced atrial inflammation indeed predisposes patients towards the development of AF. 
